A national survey of therapeutic facilities for managing hypoxic ischaemic encephalopathy in tertiary neonatal wards in South African public hospitals

Main Article Content

N N Dhlomo
M S Pepper
J van Rensburg
S Pillay
A Horn

Abstract





Background. A 2011 South African (SA) survey noted substantial variability in provision of therapeutic hypothermia (TH) for moderate- severe neonatal encephalopathy due to suspected hypoxic-ischaemic encephalopathy (NESHIE).


Objectives. To describe facilities, including TH, for babies with NESHIE in SA tertiary/specialised public hospitals.


Methods. A survey was emailed to representatives of all public tertiary/specialised hospitals with tertiary neonatal beds in SA. The survey contained questions regarding bed numbers, equipment, staffing, follow-up and barriers to the implementation of TH.


Results. Responses were received from all 25 hospitals across the nine provinces. Most hospitals (n/N=22/25; 88%) provided TH (median (range) per province: 2 (1 - 8)). The hospitals providing TH had more total neonatal beds (p=0.011) and more admissions with moderate- severe NESHIE (p=0.008) compared with those not providing TH. Most cooling centres (n/N=20/22; 91%) provided TH in their NICUs; six of these also cooled at lower levels of care. There was access to amplitude integrated electroencephalography (aEEG) and automated cooling in 91% of cooling centres. Manual cooling was used by 50% if automated TH was not available, 82% of which were validated methods. Late arrival was the most frequent barrier to provision of TH (80%).


Conclusion. All provinces and most tertiary/specialised hospitals with tertiary neonatal beds in SA provided TH in 2023. The use of acceptable monitoring and cooling methods was widespread but insufficient, and some cooling methods in use were not validated. National registers and standardised protocols for patient selection and management are needed.





Article Details

Section

Research

Author Biographies

N N Dhlomo, Division of Neonatal Medicine, Department of Paediatrics and Child Health, Groote Schuur Hospital, Faculty of Health Science, University of Cape Town, South Africa

Paediatrician and Neonatologist
Department of Paediatrics and Child Health
Nelson Mandela Academic Hospital

M S Pepper, Institute for Cellular and Molecular Medicine, Department of Medical Immunology, Faculty of Health Sciences, University of Pretoria, South Africa; Extramural Unit for Stem Cell Research and Therapy, South African Medical Research Council, Pretoria, South Africa

Research Professor, Dept Immunology
Director, Institute for Cellular and Molecular Medicine
Director, SAMRC Extramural Unit for Stem Cell Research and Therapy

J van Rensburg, Institute for Cellular and Molecular Medicine, Department of Medical Immunology, Faculty of Health Sciences, University of Pretoria, South Africa

Research Project Manager
Institute for Cellular and Molecular Medicine, Dept Immunology

S Pillay, Division of Neonatal Medicine, Department of Paediatrics and Child Health, Groote Schuur Hospital, Faculty of Health Science, University of Cape Town, South Africa

Paediatrician and Neonatologist
Division of Neonatal Medicine, Department of Paediatrics and Child Health
Groote Schuur Hospital

A Horn, Division of Neonatal Medicine, Department of Paediatrics and Child Health, Groote Schuur Hospital, Faculty of Health Science, University of Cape Town, South Africa

A/Professor, Paediatrician and Neonatologist
Division of Neonatal Medicine, Department of Paediatrics and Child `Health,
Groote Schuur Hospital, University of Cape Town, South Africa.

How to Cite

A national survey of therapeutic facilities for managing hypoxic ischaemic encephalopathy in tertiary neonatal wards in South African public hospitals. (2025). South African Journal of Child Health, 19(4), e2917. https://doi.org/10.7196/SAJCH.2025.v19i4.2917

References

1. Lee CYZ, Chakranon P, Lee SWH. Comparative efficacy and safety of neuroprotective therapies for neonates with hypoxic ischemic encephalopathy: A network meta-analysis. Front Pharmacol 2019;10:1221. https://doi.org/10.3389/ fphar.2019.01221

2. Nelson KB. Is it HIE? And why that matters. Acta Paediatr 2007;96(8):1113-1114.

https://doi.org/10.1111/j.1651-2227.2007.00364.x

3. HornAR,SwinglerGH,MyerL,etal.Defininghypoxicischemicencephalopathy in newborn infants: Benchmarking in a South African population. J Perinat Med 2013;41(2):211-217. https://doi.org/10.1515/jpm-2012-0107

4. Pillay S, Pepper MS, van Rensburg J, Horn AR. Review of seizure management and short-term outcomes in cooled babies with neonatal encephalopathy with suspected intrapartum hypoxia and seizures. S Afr J Child Health 2024;18(1b):30-32. https://doi.org/10.7196

5. Foden CJ, Durant K, Mellet J, et al. Genetic variants associated with suspected neonatal hypoxic ischaemic encephalopathy: A study in a South African Context. Int J Mol Sci 2025;26(5):2075. https://doi.org/10.3390/ijms26052075

6. Babbo CC, Mellet J, van Rensburg J, et al. Neonatal encephalopathy due to suspected hypoxic ischemic encephalopathy: Pathophysiology, current, and emerging treatments. World J Pediatr 2024;20(11):1105-1114. https://doi. org/10.1007/s12519-024-00836-9

7. Kurinczuk JJ, White-Koning M, Badawi N. Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. Early Hum Dev 2010;86(6):329-338. https://doi.org/10.1016/j.earlhumdev.2010.05.010

8. Bruckmann EK, Velaphi S. Intrapartum asphyxia and hypoxic ischaemic encephalopathy in a public hospital: Incidence and predictors of poor outcome. S Afr Med J 2015;105(4):298-303. https://doi.org/10.7196/samj.9140

9. PerlmanJM,WyllieJ,KattwinkelJ,etal.Neonatalresuscitation:2010International consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Pediatrics 2010;126(5):1319-1344. https://doi.org/10.1542/peds.2010-2972B

10. Wyckoff MH, Aziz K, Escobedo MB, et al. Part 13: Neonatal Resuscitation: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2015;132(18 Suppl 2):543-560. https://doi.org/10.1161/CIR.0000000000000267

11. Horn AR, Harrison MC, Linley L. Evaluating a simple method of neuroprotective hypothermia for newborn infants. J Trop Pediatr 2010;56(3):172-177. https://doi.org/10.1093/tropej/fmp089

12. Horn AR, Swingler GH, Myer L, et al. Early clinical signs in neonates with hypoxic ischemic encephalopathy predict an abnormal amplitude- integrated electroencephalogram at age 6 hours. BMC Pediatr 2013;13(1):52. https://doi.org/10.1186/1471-2431-13-52

13. Spitzmiller RE, Phillips T, Meinzen-Derr J, Hoath SB. Amplitude-integrated EEG is useful in predicting neurodevelopmental outcome in full-term infants with hypoxic-ischemic encephalopathy: A meta-analysis. J Child Neurol 2007;22(9):1069-1078. https://doi.org/10.1177/0883073807306258

14. Thoresen M, Hellström-Westas L, Liu X, de Vries LS. Effect of hypothermia on amplitude-integrated electroencephalogram in infants with asphyxia. Pediatrics 2010;126(1):131-139. https://doi.org/10.1542/peds.2009-2938

15. Joolay Y, Harrison MC, Horn AR. Therapeutic hypothermia and hypoxic ischemic encephalopathy: Opinion and practice of pediatricians in South Africa. J Perinat Med 2012;40(4):447-453. https://doi.org/10.1515/jpm-2011-0292

16. Kali GT, Martinez-Biarge M, Van Zyl J, Smith J, Rutherford M. Therapeutic hypothermia for neonatal hypoxic-ischaemic encephalopathy had favourable outcomes at a referral hospital in a middle-income country. Acta Paediatr 2016;105(7):806-815. https://doi.org/10.1111/apa.13392

17. South Africa. National Health Act, 2003: Regulations relating to categories of hospitals. Pretoria: Government Gazette, 2012. https://www.gov.za/sites/default/ files/gcis_document/201409/35101rg9701gon185a.pdf (accessed 20 May 2025).

18. Cape Town Neonatal Consultancy. Neonatal Guidelines and Drug Doses 2022. 6th ed. Pillay S, ed. Cape Town: Cape Town Neonatal Consultancy, 2022.

19. Robertson NJ, Kendall GS, Thayyil S. Techniques for therapeutic hypothermia during transport and in hospital for perinatal asphyxial encephalopathy. Semin Fetal Neonatal Med 2010;15(5):276-286. https://doi.org/10.1016/j. siny.2010.03.006

20. Jacobs SE, Morley CJ, Inder TE, et al. Whole-body hypothermia for term and near-term newborns with hypoxic-ischemic encephalopathy: A randomised controlled trial. Arch Pediatr Adolesc Med 2011;165(8):692-700. https://doi. org/10.1001/archpediatrics.2011.43

21. Rossouw G, Irlam J, Horn AR. Therapeutic hypothermia for hypoxic ischaemic encephalopathy using low-technology methods: A systematic review and meta-analysis. Acta Paediatr 2015;104(12):1217-1228. https://doi.org/10.1111/ apa.12830

22. Horn AR, Woods DL, Thompson C, Els I, Kroon M. Selective cerebral hypothermia for post-hypoxic neuro-protection in neonates using a solid ice cap. S Afr Med J 2006;96:976-981.

23. Nakwa FL, Sepeng L, van Kwawegen A, et al. Characteristics and outcomes of neonates with intrapartum asphyxia managed with therapeutic hypothermia in a public tertiary hospital in South Africa. BMC Pediatr 2023;23(1):51. https://doi. org/10.1186/s12887-023-03852-2

24. Azzopardi D, Brocklehurst P, Edwards D, et al. The TOBY Study. Whole body hypothermia for the treatment of perinatal asphyxial encephalopathy: A randomised controlled trial. BMC Pediatr 2008;8:17. https://doi.org/10.1186/1471-2431-8-17

25. Statistics South Africa. Recorded live births 2023. Pretoria: StatsSA, 2024. https:// www.statssa.gov.za/publications/P0305/P03052023.pdf (accessed 20 May 2025). 26. Parmentier CEJ, de Vries LS, Groenendaal F. Magnetic resonance imaging

in (near) term infants with hypoxic-ischemic encephalopathy. Diagnostics

2022;12(3):645. https://doi.org/10.3390/diagnostics12030645

27. Singla M, Chalak L, Kumar K, et al. ‘Mild’ hypoxic-ischaemic encephalopathy and therapeutic hypothermia: A survey of clinical practice and opinion from 35 countries. Neonatology 2022;119(6):712-718. https://doi.org/10.1159/000526404 28. Sebetseba KN, Ramdin T, Ballot D. The use of therapeutic hypothermia in neonates with perinatal asphyxia at Charlotte Maxeke Johannesburg Academic Hospital: A retrospective review. Ther Hypothermia Temp Manag

2020;10(3):135-140. https://doi.org/10.1089/ther.2017.0040

29. Thayyil S, Oliveira V, Lally PJ, et al. Hypothermia for encephalopathy in low and

middle-income countries (HELIX): Study protocol for a randomised controlled

trial. Trials 2017;18(1):432. https://doi.org/10.1186/s13063-017-2165-3

30. Ballot DE, Ramdin TD, Bandini RM, et al. Therapeutic hypothermia for neonatal hypoxic ischaemic encephalopathy should not be discontinued in low- and middle-income countries. S Afr Med J 2021;111(12):1168-1169. https://doi.

org/10.7196/SAMJ.2021.v111i12.16180

31. Kali GTJ, Pillay S, Pepper MS, Horn AR. Questions about the HELIX trial. Lancet Glob Health 2021;9(12):1653. https://doi.org/10.1016/S2214-109X(21)00490-3

Similar Articles

You may also start an advanced similarity search for this article.